top of page

RYGB and SG lower health care costs for T2DM patients

owenhaskins

In patients with type 2 diabetes, Roux-en-Y gastric bypass and sleeve gastrectomy for weight loss may be effective for reducing long-term health care costs, a study from Duke University School of Medicine and Kaiser Permanente has found.  The investigators reported that patients who underwent either procedure experienced significant decreases in overall health care costs afterward. However, there were no differences in costs between the two groups of patients except for a transient difference in the first six months post-surgery. 


Matthew Maciejewski
Matthew Maciejewski

“This was a head-to-head comparison of costs before and after surgery of the two most common procedures for bariatric surgery. The cost reductions were similar for both the procedures, and they were driven by a reduction in medication expenses,” Dr Matthew Maciejewski, Duke University, Durham, NC, the corresponding author of the study and a professor in the Department of Population Health Sciences at Duke University School of Medicine. He is also a senior research career scientist in the Center of Innovation to Accelerate Discovery and Practice Transformation at the Durham VA Medical Center. “The cost reductions were similar for both the procedures, and they were driven by a reduction in medication expenses.”


The retrospective cohort study analysed health care costs three years before and five and a half years after bariatric surgery. The researchers studied data about costs for medications and inpatient and outpatient care from 6,657 patients (RYGB, n=3147 or SG, n=3510) with type 2 diabetes at Kaiser Permanente Southern California and Kaiser Permanente Washington between January 2012 and December 2019. 


Characteristics of patients undergoing RYGB and SG were well balanced after weighting; 73% were female, average body mass index was 43.8kg/m2, and average age was 50 years. Expenditures per six-month period decreased by about 30% for both groups, from US$4039.06 (95% CI, US$3770.88 to US$4326.31) three years before to US$2441.13 (CI, US$2151.07 to US$2770.30) 5.5 years after RYGB and from US$3918.37 (CI, US$3658.75 to US$4196.40) three years before to US$2658.15 (CI, US$2279.17 to US$3100.16) 5.5 years after SG.


Total expenditures after surgery did not differ between groups through 5.5 years (difference at 5.5 years, −US$217.02 [CI, −US$671.29 to US$201.96]) except for the first six months, when expenditures were transiently higher in the RYGB group (difference, US$564.32 [CI, US$232.60 to US$895.20]), driven by a higher inpatient admission rate.


Otherwise, postsurgical outpatient and medication expenditures did not appear to differ between RYGB and SG.

 

Maciejewski said the study team plans to examine subgroups of bariatric surgical patients to find out if certain groups have greater potential for cost savings with each type of procedure, and to compare surgical patients to nonsurgical patients. 


The findings were featured in the paper, ‘Health Expenditures of Patients With Diabetes After Bariatric Surgery: Comparing Gastric Bypass and Sleeve Gastrectomy’, published in the Annals of Internal Medicine. To access this paper, please click here (log-in maybe required)

 

Comments


Weekly Digest

Get a round-up of the main headlines from Bariatric News, directly to your inbox each week.

Thanks for submitting!

Get in touch!
Email: info@bariatricnews.net

©2023 Dendrite Clinical Systems Ltd. All rights reserved.
No part of this website may be reproduced, stored in a retrieval system, transmitted in any form or by any other means without prior written permission from the Managing Editor. The views, comments and opinions expressed within are not necessarily those of Dendrite Clinical Systems or the Editorial Board. Bariatricnews.net is a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

bottom of page